Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
497,385,566
-
Total 13F shares
-
473,375,688
-
Share change
-
-1,428,285
-
Total reported value
-
$12,362,622,405
-
Put/Call ratio
-
153%
-
Price per share
-
$26.09
-
Number of holders
-
454
-
Value change
-
-$47,241,309
-
Number of buys
-
229
-
Number of sells
-
209
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) as of Q1 2022
As of 31 Mar 2022,
Elanco Animal Health Inc - Common Stock (ELAN) was held by
454 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
473,375,688 shares.
The largest 10 holders included
VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, Aristotle Capital Management, LLC, Dodge & Cox, Sachem Head Capital Management LP, BlackRock Inc., FRANKLIN RESOURCES INC, AMUNDI, and STATE STREET CORP.
This page lists
454
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.